Selected Tag

Justin Bekelman

All Tags 89

Learning How Behavioral Economics Impacts Health Decisions

    • Quit Smoking
    • senior couple on walk
    • laptop computer
    • Seated Exercise
    • Ladies Swimming
  • Previous
  • Next

Center for Health Incentives and Behavioral Economics Research

CHIBE researchers apply concepts from the field of behavioral economics to design, implement, and evaluate interventions that improve health and build knowledge about efficacy, cost and effectiveness. 

Basic Science Core Request for Applications

The Basic Science Core aims to support laboratory or low-cost field studies that will shed light on mechanisms that can generate behavior change.  In contrast to previous large-scale field studies, which have often combined multiple mechanisms into one intervention in order to maximize impact on behavior, basic science projects supported by the Core focus on disentangling and precisely identifying the impacts of individual mechanisms.  CHIBE researchers interested in applying for project support can click here for more information.



Health Incentives and Behavioral Economics Research Studies

You are viewing 2 posts with the tag Justin Bekelman

Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients with Stage II or III Breast Cancer

Principal Investigator: Justin Bekelman, MD 

The Radiotherapy Comparative Effectiveness (RADCOMP) Consortium will conduct a pragmatic randomized clinical trial in which 1,716 patients with stage II and III breast cancer involving lymph nodes under the arm or above the collarbone will be randomized after surgery to either proton therapy or photon therapy, the current standard treatment. Patients will be followed to determine differences in heart problems, cancer control, and health-related quality of life (HRQOL) after treatment.

Funder: PCORI

Effects of Commercial Insurer Payment Policy on Chemotherapy Use and Costs

Principal Investigator: Justin Bekelman

Over the past several years, a large, national commercial insurer implemented reimbursement changes to incentivize the use of generic chemotherapies, presenting a natural experiment which we will leverage to examine the effects of chemotherapy reimbursement policy changes on treatment patterns, quality and costs.

Funder: American Cancer Society